19-33301874-A-T

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_004364.5(CEBPA):​c.541T>A​(p.Tyr181Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Y181H) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0000070 ( 0 hom., cov: 32)
Failed GnomAD Quality Control

Consequence

CEBPA
NM_004364.5 missense

Scores

2
2
14

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 1.48

Publications

0 publications found
Variant links:
Genes affected
CEBPA (HGNC:1833): (CCAAT enhancer binding protein alpha) This intronless gene encodes a transcription factor that contains a basic leucine zipper (bZIP) domain and recognizes the CCAAT motif in the promoters of target genes. The encoded protein functions in homodimers and also heterodimers with CCAAT/enhancer-binding proteins beta and gamma. Activity of this protein can modulate the expression of genes involved in cell cycle regulation as well as in body weight homeostasis. Mutation of this gene is associated with acute myeloid leukemia. The use of alternative in-frame non-AUG (GUG) and AUG start codons results in protein isoforms with different lengths. Differential translation initiation is mediated by an out-of-frame, upstream open reading frame which is located between the GUG and the first AUG start codons. [provided by RefSeq, Dec 2013]
CEBPA-DT (HGNC:25710): (CEBPA divergent transcript)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.26324278).

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004364.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CEBPA
NM_004364.5
MANE Select
c.541T>Ap.Tyr181Asn
missense
Exon 1 of 1NP_004355.2
CEBPA
NM_001287424.2
c.646T>Ap.Tyr216Asn
missense
Exon 1 of 1NP_001274353.1P49715-4
CEBPA
NM_001287435.2
c.499T>Ap.Tyr167Asn
missense
Exon 1 of 1NP_001274364.1P49715-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CEBPA
ENST00000498907.3
TSL:6 MANE Select
c.541T>Ap.Tyr181Asn
missense
Exon 1 of 1ENSP00000427514.1P49715-1
ENSG00000267727
ENST00000587312.1
TSL:3
n.416A>T
non_coding_transcript_exon
Exon 2 of 2
CEBPA-DT
ENST00000718467.1
n.46+75A>T
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.00000704
AC:
1
AN:
141984
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000697
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD4 exome
Cov.:
33
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.00000704
AC:
1
AN:
142128
Hom.:
0
Cov.:
32
AF XY:
0.00
AC XY:
0
AN XY:
69122
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00
AC:
0
AN:
39792
American (AMR)
AF:
0.0000696
AC:
1
AN:
14358
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3370
East Asian (EAS)
AF:
0.00
AC:
0
AN:
4122
South Asian (SAS)
AF:
0.00
AC:
0
AN:
3974
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
8472
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
284
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
64860
Other (OTH)
AF:
0.00
AC:
0
AN:
2016
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.225
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.21
BayesDel_addAF
Benign
-0.17
T
BayesDel_noAF
Benign
-0.48
CADD
Benign
22
DANN
Benign
0.76
DEOGEN2
Benign
0.25
T
Eigen
Benign
-0.19
Eigen_PC
Benign
-0.19
FATHMM_MKL
Benign
0.68
D
LIST_S2
Benign
0.59
T
M_CAP
Pathogenic
0.63
D
MetaRNN
Benign
0.26
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.1
L
PhyloP100
1.5
PrimateAI
Pathogenic
0.90
D
PROVEAN
Benign
-1.3
N
REVEL
Benign
0.054
Sift
Uncertain
0.024
D
Sift4G
Uncertain
0.027
D
Polyphen
0.94
P
Vest4
0.31
MutPred
0.19
Loss of phosphorylation at Y181 (P = 0.0077)
MVP
0.27
ClinPred
0.31
T
GERP RS
3.6
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.14
gMVP
0.38
Mutation Taster
=83/17
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1060502124; hg19: chr19-33792780; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.